We report a rare case of primary small bowelCD5+ DLBCL that evolved from being a localized low International PrognosticIndex–scored disease into an advanced and aggressive disease primarily dictatedby the presence of CD5 antigen positivity. This evidence concerns the gene CD5 and diffuse large B-cell lymphoma.